Research policy

The Initiative on Genomics & Public Health



Genomics in WHO

Global Malaria Program

The WHO Global Malaria Programme (GMP) is one of the two WHO arms that deal with Malaria (the other one is TDR - Research and Training for Tropical Diseases). GMP's policy advice provides the benchmark for national malaria programmes and multilateral funding agencies. GMP’s activities are focused on providing an integrated solution to the various epidemiological and operational challenges. This is achieved through the promotion of sound, evidence-based and locally appropriate strategies. The Programme helps countries reach the most vulnerable populations and ensure that needed interventions take into account social, economic and environmental realities.

The WHO Global Malaria Programme supports national malaria programmes worldwide. GMP teams provide technical assistance at country level on five main topics:

  • diagnosis and treatment (diagnostic tools, medicines and patient management);
  • vector control (mosquiton control, reduce the risk of infection for local populations and international travelers);
  • surveillance and monitoring (generating data for decision making, quality assurance);
  • elimination of malaria (expanding malaria-free areas of the world);
  • research (improving tools to combat malaria).
Diagnosis

GMP has been actively working on the next generation molecular diagnostic tool for malaria in collaboration with Foundation for innovative new diagnostics (FIND). The Loop-mediate isothermal amplification (LAMP) based malaria diagnostic tool, which amplifies parasites' DNA signals without PCR amplification cycle therefore bypass the requirement of thermal cycle, is an example.

Share